Your session is about to expire
← Back to Search
Biosynthetic Mesh
Phasix Mesh for Ventral Hernia
N/A
Waitlist Available
Led By Julie Holihan, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial is comparing different types of meshes used in complex ventral hernia repairs to see which one results in the best outcomes for patients. The primary outcome measure is the number of patients who don't have any major complications 2 years after surgery.
Eligible Conditions
- Ventral Hernia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Major complication free
Secondary outcome measures
Clavien-Dindo complication grade
Cost Analysis
Emergency room visits
+4 moreTrial Design
2Treatment groups
Active Control
Group I: Phasix MeshActive Control1 Intervention
Phasix mesh will be used in the repair of the hernia
Group II: Current CareActive Control1 Intervention
The hernia will be repaired with either synthetic mesh or suture repair, as determined by the operating surgeon.
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,977 Total Patients Enrolled
Julie Holihan, MDPrincipal InvestigatorUTHealth
2 Previous Clinical Trials
663 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are candidates invited to participate in this clinical research experiment?
"As indicated on clinicaltrials.gov, this particular medical trial is not taking in new participants at the present moment. Initially posted on October 1st 2020, and edited a day later, it has since been concluded that no additional patients are needed for the study - however there remain 160 other experiments currently recruiting individuals to partake in them."
Answered by AI
Share this study with friends
Copy Link
Messenger